BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3501245)

  • 1. Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.
    Gerdes J; Pickartz H; Brotherton J; Hammerstein J; Weitzel H; Stein H
    Am J Pathol; 1987 Dec; 129(3):486-92. PubMed ID: 3501245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between growth fractions and oestrogen receptors in human breast carcinoma, as determined by immunohistochemical staining.
    Raymond WA; Leong AS
    J Pathol; 1989 Jul; 158(3):203-11. PubMed ID: 2769481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
    Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
    J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity and steroid receptors determined by immunohistochemistry in adjacent frozen sections of 102 breast carcinomas.
    Helin ML; Helle MJ; Helin HJ; Isola JJ
    Arch Pathol Lab Med; 1989 Aug; 113(8):854-7. PubMed ID: 2667495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
    Reiner A; Spona J; Reiner G; Schemper M; Kolb R; Kwasny W; Függer R; Jakesz R; Holzner JH
    Am J Pathol; 1986 Dec; 125(3):443-9. PubMed ID: 3541638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
    Hendricks JB; Wilkinson EJ
    Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.
    Domagala W; Lasota J; Bartkowiak J; Weber K; Osborn M
    Am J Pathol; 1990 Jan; 136(1):219-27. PubMed ID: 2153347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
    Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
    Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.
    Brock JE; Hornick JL; Richardson AL; Dillon DA; Lester SC
    Am J Clin Pathol; 2009 Sep; 132(3):396-401. PubMed ID: 19687316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
    J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody.
    Huang A; Pettigrew NM; Watson PH
    J Pathol; 1996 Oct; 180(2):223-7. PubMed ID: 8976884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies for the immunohistochemical detection of estrogen receptor status in tissue sections of primary breast cancers].
    Beck T; Pollow K; Heubner A
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):490-4. PubMed ID: 3530871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
    Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
    Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome.
    Iguchi C; Nio Y; Itakura M
    J Surg Oncol; 2003 Jun; 83(2):85-93. PubMed ID: 12772201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.